Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
DIA 2021 Global Annual Meeting
PMDA Town Hall
Session Chair(s)
Nobumasa Nakashima, PhD
- Associate Executive Director for International Programs
- Pharmaceuticals and Medical Devices Agency (PMDA), Japan
PMDA’s activity is based on "4Fs" (Patient First, Access First, Safety First, Asia First) as priority policy, which Dr. Fujiwara, chief executive, has set up. In this session, PMDA will introduce its efforts around "4Fs" including those for COVID19.
Learning Objective : Describe the latest information regarding PMDA and Japanese regulations; Discuss how to foster dialogue between participants and senior PMDA officials concerning drug/device regulatory challenges.
Speaker(s)
Panelist
Fumi Yamamoto
- Councilor for Pharmaceutical Affairs, Minister’s Secretariat
- Ministry of Health, Labour and Welfare (MHLW), Japan
Panelist
Yasuhiro Fujiwara, MD, PhD
- Chief Executive
- Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Panelist
Kenichi Tamiya, MSc, RPh
- Associate Executive Director
- Pharmaceuticals and Medical Devices Agency (PMDA), Japan